|
Comprehensive geriatric assessment and management for Canadian elders with Cancer: The 5C study. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Apobiologix; Genomic Health; Ipsen |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Apobiologix; Exact Sciences; Novartis; Sandoz |
Expert Testimony - Genentech/Roche |
| |
|
Honoraria - Eisai; Novartis |
Consulting or Advisory Role - Bayer; Eisai |
Research Funding - Eisai (Inst); Exelixis (Inst); Ipsen (Inst) |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Stock and Other Ownership Interests - ResMed |
Honoraria - Astellas Scientific and Medical Affairs Inc |